113 related articles for article (PubMed ID: 38305287)
1. Differential Expression of KIF18B in Gastric Cancer and Its Role in Chemotherapy Sensitivity.
Gan LH; Yao L; Yan JH; Huang YQ; Zheng L; Liu P; Lei L
Crit Rev Eukaryot Gene Expr; 2024; 34(3):37-48. PubMed ID: 38305287
[TBL] [Abstract][Full Text] [Related]
2. Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal Transition.
Ishikawa A; Yasumatsu R; Fukui T; Kido A; Katsuya N; Sentani K; Kuraoka K; Oue N; Suzuki T; Oka S; Kotachi T; Tanabe K; Ohdan H; Ashktorab H; Smoot D; Yasui W
Oncology; 2024; 102(4):354-365. PubMed ID: 37812924
[TBL] [Abstract][Full Text] [Related]
3. miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer.
Ke H; Wu S; Zhang Y; Zhang G
Bioengineered; 2022 Feb; 13(2):4528-4536. PubMed ID: 35137670
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of KIF18B facilitates malignant phenotype of esophageal squamous cell carcinoma by activating CDCA8/mTORC1 pathway.
Xie J; Wang B; Luo W; Li C; Jia X
J Clin Lab Anal; 2022 Oct; 36(10):e24633. PubMed ID: 36085568
[TBL] [Abstract][Full Text] [Related]
5. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
6. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
Zhao EH; Shen ZY; Liu H; Jin X; Cao H
World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer.
Shan T; Fan J; Zhao Q; Deng K; Xia J
Mol Med Rep; 2017 Oct; 16(4):3761-3768. PubMed ID: 28731138
[TBL] [Abstract][Full Text] [Related]
9. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
10. CircHN1 affects cell proliferation and migration in gastric cancer.
Zhang Y; Wang M; Zang X; Mao Z; Chen Y; Mao F; Qian H; Xu W; Zhang X
J Clin Lab Anal; 2020 Oct; 34(10):e23433. PubMed ID: 32608539
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
12. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
13. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
[TBL] [Abstract][Full Text] [Related]
14. PRSS2 overexpression relates to poor prognosis and promotes proliferation, migration and invasion in gastric cancer.
Chen Y; Wang B; Zhao Z; Li M; Wang F
Tissue Cell; 2022 Dec; 79():101949. PubMed ID: 36240716
[TBL] [Abstract][Full Text] [Related]
15. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
17. circRNA RNF111 regulates the growth, migration and invasion of gastric cancer cells by binding to miR‑27b‑3p.
Wang Z; Jiang Z; Zhou J; Liu Z
Int J Mol Med; 2020 Nov; 46(5):1873-1885. PubMed ID: 33000178
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway.
Zhang W; Liu Z
Pharmacogenet Genomics; 2023 Jan; 33(1):1-9. PubMed ID: 36441170
[TBL] [Abstract][Full Text] [Related]
19. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
